<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">M. Arbyn</style></author><author><style face="normal" font="default" size="100%">Cuzick, Jack</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">International agreement to join forces in synthesizing evidence on new methods for cervical cancer prevention.</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Lett</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Cancer Lett.</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Carcinoma in Situ</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Meta-Analysis as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Papillomavirus Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">Precancerous Conditions</style></keyword><keyword><style  face="normal" font="default" size="100%">Randomized Controlled Trials as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">risk</style></keyword><keyword><style  face="normal" font="default" size="100%">Societies, Medical</style></keyword><keyword><style  face="normal" font="default" size="100%">Uterine Cervical Neoplasms</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009 Jun 08</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">278</style></volume><pages><style face="normal" font="default" size="100%">1-2</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Recently published baseline results of randomised controlled trials, comparing cytology with HPV-based cervical cancer screening, consistently show increased detection of high-grade cervical intraepithelial neoplasia (CIN) in the HPV-arm. These results are in line with the pooled estimates of the relative sensitivity derived from cross-sectional studies. From two randomised trials, also the longitudinal outcomes observed at the second screening round were reported. HPV-negative women, had a relative risk of developing CIN3 in the next 3 to 5 years, compared to cytology-negative women, of 0.53 (95% CI: 0.29-0.92) and 0.45 (95% CI: 0.28-0.67), respectively in the Swedish and Dutch trial. Consensus was reached at the Cochrane Workshop on Cervical Cancer Prevention, organized at the occasion of the 24th Conference of the International Papillomavirus Society, to join forces to conduct future meta-analyses of the HPV screening trials and to synthesize evidence on new methods for cervical cancer prevention.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/18930588?dopt=Abstract</style></custom1></record></records></xml>